索引超出了数组界限。
[1] 葛均波. 开拓新兴介入技术 发展多元介入治疗[J]. 中国介入心脏病学杂志, 2013, 21(1):1.
[2] Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis[J]. Circulation, 2004, 110(7):810-814.
[3] Sergie Z, Dangas GD. In-stent restenosis of bifurcation lesions: experience with drug-eluting balloons[J]. Catheter Cardiovasc Interv, 2012, 79(3):397-398.
[4] 《药物涂层球囊临床应用中国专家共识》专家组. 药物涂层球囊临床应用中国专家共识[J]. 中国介入心脏病学杂志, 2016, 24(2):61-67.
[5] Zeymer U, Waliszewski M, Spiecker M, et al. Prospective real world' registry for the use of the 'PCB only' strategy in small vessel de novo lesions[J]. Heart, 2014, 100(4):311-316.
[6] 中华医学会心血管病学分会. 不稳定性心绞痛和非ST段抬高心肌梗死诊断和治疗指南[J]. 中华心血管病杂志, 2007, 35(4):295-304.
[7] Alfonso F, García-Guimaraes M. Optimal coronary interventions in small vessels: is size all that matters?[J] JACC Cardiovasc Interv, 2016, 9(13):1335-1337.
[8] Cortese B, Micheli A, Picchi A, et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study[J]. Heart, 2010, 96(16):1291-1296.
[9] Latib A, Colombo A, Castriota F, et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO(Balloon Elution and Late Loss Optimization)study[J]. J Am Coll Cardiol, 2012, 60(24):2473-2480.
[10] Vaquerizo B, Miranda-Guardiola F, Fernández E, et al. Treatment of small vessel disease with the paclitaxel drug-eluting balloon: 6-month angiographic and 1-year clinical outcomes of the Spanish multicenter registry[J]. J Interv Cardiol, 2015, 28(5):430-438.